Abstract:Objective To study the effects of peroxisome proliferators-activated receptor γ (PPARγ) agonists on transforming growth factor (TGF)-β1-induced fibrotic responses in renal fibroblasts, so as to investigate its effects in prevention of tubulointerstitial fibrosis. Methods Rat renal fibroblasts of the line NRK/49F were cultured and divided into groups. In group 1 TGFβ1 of the concentrations of 0, 1, 2, 5, and 10 ng/ml was added and co-cultured for 24 h. In group 2 TGFβ1 of the concentration of 5 ng/ml was added and co-cultured for 0, 6, 12, and 24 h respectively. Groups 3, 4, and 5 were pretreated with 10 μmol/L15d-PGJ2, PPARγ ligand, 10 μmol/L troglitazone, agonist of, and 10 μmol/L ciglitazone, both PPARγ agonists, respectively for 2 h, then treated with 5 ng/ml TGFβ1. A blank control group was set up. The cultured cells were collected. RT-PCR was used to detect the mRNA expression of TGF-β1-indued fibronectin (FN). Western blotting was used to detect the expression of TGF-β1-induced FN, Smad, and phosphorylated Smad (p-Smad) proteins. Results TGF-β1 enhanced the FN mRNA expression in a dose- and time-dependent manner. The FN mRNA expression of the 5 ng/ml TGF-β1 group was 3.7 times that of the control group (P0.05). The FN mRNA expression of the 15d-PGJ2, troglitazone-, and ciglitazone-pretreated groups were lower than that of the 5 ng/ml TGF-β1 group by 37.3%, 41.5%, and 22.7% respectively (all P0.05). The p-Smad2/3 protein expression levels of the TGF-β1 group began to increase 15 minutes after stimulation, increased in a time-dependent manner, peaked 1 hour after, and began to decrease 2 hours later. However, the levels of protein expression of total Smad2 and Smad3 did not change significantly in all groups. Both 2 ng/ml TGFβ1 and 5 ng/mlTGFβ1 significantly induced the increase of protein expression of p-Smad2/3 (all P0.05). The levels of protein expression of p-Smad2 and p-Smad3 of the 5 ng/mlTGFβ1 group were 3.42 and 0.97 times those of the 2 ng/mlTGFβ1 (both P0.05). The levels of protein expression of p-Smad2/3 of the 15d-PGJ2, troglitazone-, and ciglitazone -pretreated groups were all significantly lower than that of the 5 ng/mlTGFβ1 group by 61.2%, 53.0%, and 59.5%(all P0.05), However, there was no significant difference among different drug-treated groups (all P0.05). Conclusion Possibly through abrogating TGF-β1/Smads signaling pathway, PPARγ agonists inhibit TGF-β1-induced renal fibroblast extracellular matrix synthesis and may play a potential role in preventing tubulointerstitial fibrosis as a novel approach to prevent the progress of end stage renal dysfunction.

Brain Natriuretic Peptide Mitigates TIMP2 Induction and Reinstates Extracellular Matrix Catabolic Activity Via GSK3β Inhibition in Glomerular Podocytes Exposed to a Profibrogenic Milieu.

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

Pharmacological Targeting of GSK3β Confers Protection Against Podocytopathy and Proteinuria by Desensitizing Mitochondrial Permeability Transition

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Fine-tuning of NFκB by Glycogen Synthase Kinase 3β Directs the Fate of Glomerular Podocytes Upon Injury.

Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis

Brain Natriuretic Peptide Modulates the Delayed Rectifier Outward K+ Current and Promotes the Proliferation of Mouse Schwann Cells

Permissive Effect of GSK3β on Profibrogenic Plasticity of Renal Tubular Cells in Progressive Chronic Kidney Disease.

Beclin-1-Derived - Derived Peptide MP1 Attenuates Renal Fibrosis by Inhibiting the Wnt//3-Catenin /3-Catenin PathwayS S

Beclin-1-derived peptide MP1 attenuates renal fibrosis by inhibiting the Wnt/β-Catenin pathway

Fine-Tuning Of Nf Kappa B By Glycogen Synthase Kinase 3 Beta Directs The Fate Of Glomerular Podocytes Upon Injury

GSK3β-dependent Lysosome Biogenesis: an Effective Pathway to Mitigate Renal Fibrosis with LM49

The protective effect of the EP2 receptor on TGF-β1 induced podocyte injury via the PI3K / Akt signaling pathway

Identification of natriuretic peptide receptor A-related gene expression signatures in podocytes in vivo reveals baseline control of protective pathways

Berberine Reduces Fibronectin Expression by Suppressing the S1P-S1P2 Receptor Pathway in Experimental Diabetic Nephropathy Models

Targeting the transmembrane cytokine co-receptor neuropilin-1 in distal tubules improves renal injury and fibrosis

Therapeutic Effects of Continuous Infusion of Brain Natriuretic Peptides on Postmyocardial Infarction Ventricular Remodelling in Rats.

Novel Aspect of Neprilysin in Kidney Fibrosis Via ACSL4-mediated Ferroptosis of Tubular Epithelial Cells.

Ginkgo Biloba Leaf Extract Prevents Diabetic Nephropathy Through the Suppression of Tissue Transglutaminase

Mkp2 Inhibits Tgf-Beta 1-Induced Epithelial-To-Mesenchymal Transition In Renal Tubular Epithelial Cells Through A Jnk-Dependent Pathway

Effects of Peroxisome Proliferators-Activated Receptor Γ Agonists on Transforming Growth Factor-Β1 and Smads Signal Pathway: Experiment with Rat Renal Fibroblasts